Medical Services & Devices
Eli Lilly has agreed to purchase biopharmaceutical company AtaiBeckley, which is developing psychedelic-based therapies for treatment-resistant depression
Eli Lilly has agreed to purchase biopharmaceutical company AtaiBeckley, which is developing psychedelic-based therapies for treatment-resistant depression
Articles
Johnson & Johnson is investing more than US$1bn in Florida to expand ACUVUE production, strengthen supply chains and advance eye healthcare innovation
GSK is set to acquire oncology therapy specialist Nuvalent for US$10.6bn, adding three lung cancer assets and strengthening its precision medicine pipeline
Pharmaceutical firm Perrigo replaces CEO Patrick Lockwood-Taylor after conduct concerns, appointing an interim Chief amid strategy and nutrition review
GSK is set to acquire oncology therapy specialist Nuvalent for US$10.6bn, adding three lung cancer assets and strengthening its precision medicine pipeline
Johnson & Johnson is investing more than US$1bn in Florida to expand ACUVUE production, strengthen supply chains and advance eye healthcare innovation
Johnson & Johnson is acquiring Firefly Bio for US$1bn, adding its degrader antibody conjugate platform to target KRAS-driven cancers & expand oncology
As climate change drives more frequent heatwaves, health experts warn high temperatures can affect medicines, dehydration risk and treatment safety
Lists
From UnitedHealthcare's Stephanie Fehr and J&J's Kristen Mulholland to McKesson's LeAnn Smith & CVS Health's Heidi Capozzi, meet the top Chief HR Officers
From Johnson & Johnson and Roche to Eli Lilly, Pfizer, Novartis, Merck & Co and AstraZeneca, these life sciences leaders are advancing healthcare systems
Videos
Early in the COVID-19 pandemic Moderna teamed up with Apply Digital to lead its digital transformation and educate the world about Moderna’s mRNA platform